Connor W E, Connor S L
Department of Medicine, Oregon Health Sciences University, Portland.
Adv Intern Med. 1990;35:139-71.
The principal goal of dietary prevention and treatment of atherosclerotic coronary heart disease is the achievement of physiological levels of the plasma total and LDL cholesterol, triglyceride, and VLDL. These goals have been well delineated by the National Cholesterol Education Program of the National Heart, Lung and Blood Institute and the American Heart Association. Dietary treatment is first accomplished by enhancing LDL receptor activity and at the same time depressing liver synthesis of cholesterol and triglyceride. Both dietary cholesterol and saturated fat decrease LDL receptor activity and inhibit the removal of LDL from the plasma by the liver. Saturated fat decreases LDL receptor activity, especially when cholesterol is concurrently present in the diet. The total amount of dietary fat is of importance also. The greater the flux of chylomicron remnants is into the liver, the greater is the influx of cholesterol ester. In addition, factors that affect VLDL and LDL synthesis could be important. These include excessive calories (obesity), which enhance triglyceride and VLDL and hence LDL synthesis. Weight loss and omega-3 fatty acids from fish oil depress synthesis of both VLDL and triglyceride in the liver. The optimal diet for the treatment of children and adults to prevent coronary disease has the following characteristics: cholesterol (100 mg/day), total fat (20% of calories, 6% saturated with the balance from omega-3 and omega-6 polyunsaturated and monounsaturated fat), carbohydrate (65% of calories, two thirds from starch including 11 to 15 gm of soluble fiber), and protein (15% of calories). This low-fat, high-carbohydrate diet can lower the plasma cholesterol 18% to 21%. This diet is also an antithrombotic diet, thrombosis being another major consideration in preventing coronary heart disease. Dietary therapy is the mainstay of the prevention and treatment of coronary heart disease through the control of plasma lipid and lipoprotein levels. The exact place of the omega-3 fatty acids from fish and fish oil remains to be defined. However, this much seems certain. Fish provides an excellent substitute for meat in the diet. Fish is lower in fat, especially saturated fat, and contains the omega-3 fatty acids. Fish oil may have promise as a therapeutic agent in certain hyperlipidemic states, especially the chylomicronemia of type V hyperlipidemia. Fish oil has logical and well-defined antithrombotic and anti-atherosclerotic activities since it depresses thromboxane A2 production and inhibits cellular proliferation responsible for the progression of atherosclerosis.(ABSTRACT TRUNCATED AT 400 WORDS)
通过饮食预防和治疗动脉粥样硬化性冠心病的主要目标是使血浆总胆固醇、低密度脂蛋白胆固醇、甘油三酯和极低密度脂蛋白达到生理水平。美国国立心肺血液研究所的国家胆固醇教育计划和美国心脏协会已经明确界定了这些目标。饮食治疗首先通过增强低密度脂蛋白受体活性来实现,同时抑制肝脏中胆固醇和甘油三酯的合成。饮食中的胆固醇和饱和脂肪都会降低低密度脂蛋白受体活性,并抑制肝脏从血浆中清除低密度脂蛋白。饱和脂肪会降低低密度脂蛋白受体活性,尤其是当饮食中同时存在胆固醇时。饮食脂肪的总量也很重要。乳糜微粒残粒进入肝脏的通量越大,胆固醇酯的流入量就越大。此外,影响极低密度脂蛋白和低密度脂蛋白合成的因素可能也很重要。这些因素包括热量过多(肥胖),这会增加甘油三酯和极低密度脂蛋白,进而增加低密度脂蛋白的合成。减肥以及鱼油中的ω-3脂肪酸会抑制肝脏中极低密度脂蛋白和甘油三酯的合成。用于预防冠心病的儿童和成人最佳饮食具有以下特点:胆固醇(每日100毫克)、总脂肪(占热量的20%,6%为饱和脂肪,其余来自ω-3和ω-6多不饱和脂肪及单不饱和脂肪)、碳水化合物(占热量的65%,三分之二来自淀粉,包括11至15克可溶性纤维)和蛋白质(占热量的15%)。这种低脂、高碳水化合物饮食可使血浆胆固醇降低18%至21%。这种饮食也是一种抗血栓形成饮食,血栓形成是预防冠心病的另一个主要考虑因素。饮食疗法是通过控制血浆脂质和脂蛋白水平来预防和治疗冠心病的主要手段。来自鱼类和鱼油的ω-3脂肪酸的确切作用仍有待确定。然而,有一点似乎是肯定的。鱼类是饮食中肉类的绝佳替代品。鱼类脂肪含量较低,尤其是饱和脂肪含量低,并且含有ω-3脂肪酸。鱼油在某些高脂血症状态下,尤其是V型高脂血症的乳糜微粒血症中,可能有望作为一种治疗药物。鱼油具有合理且明确的抗血栓形成和抗动脉粥样硬化活性,因为它会抑制血栓素A2的产生,并抑制导致动脉粥样硬化进展的细胞增殖。(摘要截选至400词)